Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$19.3MFederal grants as PI22 awards
4Patents grantedLatest Dec 30, 2025
46Papers7,771 citations
Federal awards and patents by year
AwardsPatents
22 awards · $19.3M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 7, 2026 | NIH | SBIR Phase II Preclinical development of a novel therapeutic for Parkinson's disease | $3.0M | SINOPIA BIOSCIENCES INC |
| Mar 1, 2024 | NIH | SBIR Phase II Preclinical development of a novel therapeutic for Parkinson's disease | $1.3M | SINOPIA BIOSCIENCES INC |
| Aug 30, 2023 | NIH | SBIR Phase II Preclinical development of a novel therapeutic for Parkinson's disease | $100K | SINOPIA BIOSCIENCES INC |
| Mar 20, 2023 | NIH | SBIR Phase II Preclinical development of a novel therapeutic for Parkinson's disease | $1.5M | SINOPIA BIOSCIENCES INC |
| Mar 1, 2023 | NIH | SBIR Phase II Preclinical development of a novel therapeutic for Parkinson's disease | $1.6M | SINOPIA BIOSCIENCES INC |
| Feb 11, 2022 | NIH | SBIR Phase II Development of a metabolomics and machine learning based high-throughput screening platform for data-driven drug discovery | $872K | SINOPIA BIOSCIENCES INC |
| Sep 17, 2021 | NIH | SBIR Phase II Preclinical development of a novel therapeutic for Parkinson's disease | $578K | SINOPIA BIOSCIENCES INC |
| Feb 5, 2021 | NIH | SBIR Phase II Development of a metabolomics and machine learning based high-throughput screening platform for data-driven drug discovery | $1.3M | SINOPIA BIOSCIENCES INC |
| May 1, 2020 | NIH | SBIR Phase II Developing a systems biology platform for predicting, preventing, and treating drug side effects | $754K | SINOPIA BIOSCIENCES INC |
| Apr 26, 2019 | NIH | SBIR Phase II Developing a systems biology platform for predicting, preventing, and treating drug side effects | $803K | SINOPIA BIOSCIENCES INC |
| Apr 1, 2019 | NIH | SBIR Phase I Improving safety and efficacy of platelet pathogen inactivation techniques through systems biology | $224K | SINOPIA BIOSCIENCES INC |
| Mar 5, 2019 | NIH | SBIR Phase I Improving safety and efficacy of platelet pathogen inactivation techniques through systems biology | $224K | SINOPIA BIOSCIENCES INC |
| Aug 29, 2018 | NIH | SBIR Phase I Development of a metabolomics and machine learning based high-throughput screening platform for data-driven drug discovery | $442K | SINOPIA BIOSCIENCES INC |
| Mar 21, 2018 | NIH | SBIR Phase II Improving safety and efficacy of platelet transfusion through systems biology | $429K | SINOPIA BIOSCIENCES INC |
| Jun 15, 2017 | NIH | SBIR Phase II Improving safety and efficacy of platelet transfusion through systems biology | $1.5M | SINOPIA BIOSCIENCES INC |
| Jun 14, 2017 | NIH | SBIR Phase II Improving safety and efficacy of platelet transfusion through systems biology | $1.1M | SINOPIA BIOSCIENCES INC |
| May 26, 2017 | NIH | SBIR Phase II Improving red blood cell transfusion through systems biology | $443K | SINOPIA BIOSCIENCES INC |
| Sep 13, 2016 | NIH | SBIR Phase I Developing a Systems Biology Platform for Predicting Drug Toxicity and Safety | $191K | SINOPIA BIOSCIENCES INC |
| Aug 15, 2016 | NIH | SBIR Phase II Improving red blood cell transfusion through systems biology | $1.5M | SINOPIA BIOSCIENCES INC |
| Aug 15, 2016 | NIH | SBIR Phase II Improving red blood cell transfusion through systems biology | $1.0M | SINOPIA BIOSCIENCES INC |
| Aug 1, 2015 | NIH | SBIR Phase I Improving safety and efficacy of platelet transfusion through systems biology | $224K | SINOPIA BIOSCIENCES INC |
| Jun 30, 2015 | NIH | SBIR Phase I Improving safety and efficacy of platelet transfusion through systems biology | $224K | SINOPIA BIOSCIENCES INC |
5 patents as inventor
- US 10350212SINOPIA BIOSCIENCES INCJul 16, 2019
- US 11628170SINOPIA BIOSCIENCES INCApr 18, 2023
- US 12268691SINOPIA BIOSCIENCES INCApr 8, 2025
- US 12508267SINOPIA BIOSCIENCES INCDec 30, 2025
- US SINOPIA BIOSCIENCES INC—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#7
Awards as PI#13
Patents#41
Companies
- SINOPIA BIOSCIENCES INCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.